HEM Pharma approved for phase 2 clinical trial in Australia for treatment of low anterior resection syndrome
2023.03.06
|
---|
Read more >>>> https://www.edaily.co.kr/news/read?newsId=02072966635540696&mediaCodeNo=257&OutLnkChk=Y https://newsis.com/view/?id=NISX20230306_0002215965&cID=10434&pID=13200 |